Lnbeta 5 Tablet is a combination antihypertensive medication containing Nebivolol 5mg and Cilnidipine 10mg, indicated for the management of essential hypertension. Nebivolol, a highly selective beta-1 adrenergic receptor blocker, exerts its antihypertensive effect by reducing heart rate and myocardial contractility, thereby decreasing cardiac output. Additionally, Nebivolol promotes vasodilation through nitric oxide release, contributing to peripheral resistance reduction. Cilnidipine, a dihydropyridine calcium channel blocker, inhibits L-type and N-type calcium channels, leading to vasodilation of peripheral arteries and reduction of sympathetic nerve activity, which further aids in blood pressure control. The combined action of these two agents provides effective and sustained blood pressure reduction, minimizing the risk of cardiovascular events associated with hypertension. Lnbeta 5 Tablet is generally well tolerated; however, it should be used cautiously in patients with bradycardia, heart block, or severe hepatic impairment. Common adverse effects may include headache, dizziness, fatigue, and peripheral edema. Regular monitoring of blood pressure, heart rate, and renal function is recommended during therapy. This combination therapy offers a synergistic approach to hypertension management, improving patient compliance by reducing pill burden.